VR headsets could replace pills for anxiety and depression

NCT ID NCT07250971

Completed Symptom relief Sponsor: Istanbul Aydın University Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether virtual reality (VR) sessions can help reduce anxiety and depression in people aged 12 to 25 who do not want to take medication. Forty participants completed five weekly VR sessions focused on relaxation, coping skills, and healthy habits. Researchers measured changes in depression and anxiety scores before and after the program.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Virtual reality-based psychotherapeutic program (behavioral intervention using Meta Quest 2 headsets)
What this could lead to: If it works, this could offer a non-drug treatment option for young people with anxiety or depression who avoid medication.
What could go wrong: This is a small, early feasibility study with only 40 participants and no control group. Results may not apply to everyone, and side effects like dizziness or nausea are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANXIETY DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety disorder Depression depressive disorder Psychological Well-Being

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANXIETY DISORDERS DEPRESSIVE DISORDERS

Contacts and locations

Locations

Istanbul Aydın University, Department of Child and Adolescent Psychiatry

Istanbul, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.